Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study

[1]  G. Cao,et al.  Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma. , 2014, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[2]  R. Ni,et al.  Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  J. Jang,et al.  Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma , 2014, Journal of viral hepatitis.

[4]  Hongbing Shen,et al.  New loci associated with chronic hepatitis B virus infection in Han Chinese , 2013, Nature Genetics.

[5]  G. Cao,et al.  HLA-DP Polymorphisms Affect the Outcomes of Chronic Hepatitis B Virus Infections, Possibly through Interacting with Viral Mutations , 2013, Journal of Virology.

[6]  Sheng-Nan Lu,et al.  Role of Viral Genotypes and Hepatitis B Viral Mutants in the Risk of Hepatocellular Carcinoma Associated with Hepatitis B and C Dual Infection , 2013, Intervirology.

[7]  G. Cao,et al.  Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma , 2013, Hepatology.

[8]  S. Friedman,et al.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. , 2013, Gastroenterology.

[9]  Qiang Ding,et al.  Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinoma , 2012, Nature Genetics.

[10]  Hongbing Shen,et al.  GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers , 2012, PLoS genetics.

[11]  Hongbing Shen,et al.  Genetic variants in human leukocyte antigen/DP‐DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development , 2012, Hepatology.

[12]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[13]  Y. Kamatani,et al.  A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. , 2011, Human molecular genetics.

[14]  G. Cao,et al.  A matched case–control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma , 2011, Journal of medical virology.

[15]  G. Cao,et al.  Association Between the Various Mutations in Viral Core Promoter Region to Different Stages of Hepatitis B, Ranging of Asymptomatic Carrier State to Hepatocellular Carcinoma , 2011, The American Journal of Gastroenterology.

[16]  Jianren Gu,et al.  Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma. , 2011, Carcinogenesis.

[17]  V. Mazzaferro,et al.  Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis , 2010, PLoS pathogens.

[18]  G. Cao,et al.  Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma , 2010, Journal of Gastroenterology.

[19]  G. Cao,et al.  Distribution and Hepatocellular Carcinoma–Related Viral Properties of Hepatitis B Virus Genotypes in Mainland China: A Community-Based Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[20]  G. Cao Clinical relevance and public health significance of hepatitis B virus genomic variations. , 2009, World journal of gastroenterology.

[21]  B. McMahon,et al.  The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B , 2009, Hepatology international.

[22]  Y. Kamatani,et al.  A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians , 2009, Nature Genetics.

[23]  M. Yuen,et al.  Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. , 2009, Journal of hepatology.

[24]  G. Qian,et al.  Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. , 2008, Journal of hepatology.

[25]  P. Zhang,et al.  Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. , 2008, Carcinogenesis.

[26]  G. Cao,et al.  Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China , 2008, Gut.

[27]  Chien-Jen Chen,et al.  Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma , 2008, Journal of the National Cancer Institute.

[28]  V. Wong,et al.  High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Chien-Jen Chen,et al.  Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. , 2008, Carcinogenesis.

[30]  Shu Zheng,et al.  Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma , 2007, Hepatology.

[31]  F. Zoulim,et al.  Hepatitis B virus genetic variability and evolution. , 2007, Virus research.

[32]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[33]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[34]  P. Coursaget,et al.  Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes , 2004, Intervirology.

[35]  M. Buti [Hepatitis B virus genotypes]. , 2003, Gastroenterologia y hepatologia.

[36]  A. Lok,et al.  HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. , 2002, Hepatology.

[37]  Chien-Jen Chen,et al.  Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.

[38]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[39]  C. Dauguet,et al.  Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection , 1991, Journal of virology.

[40]  T. Gojobori,et al.  Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[41]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.